In advanced NSCLC, elevated FoxP3+CD4+ TIL infiltration was associated with improved progression-free and overall survival (67), potentially reflecting regulatory T cell-mediated mitigation of T cell exhaustion. The gene discussed is CD4; the disease is non-small cell lung carcinoma.